The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 15, 2019
Filed:
Mar. 15, 2013
Applicant:
Purdue Pharma L.p., Stamford, CT (US);
Inventors:
Benjamin Oshlack, New York, NY (US);
Hua-Pin Huang, Englewood Cliffs, NJ (US);
John Masselink, Old Tappan, NJ (US);
Alfred P. Tonelli, Congers, NY (US);
Assignee:
Purdue Pharma L.P., Stamford, CT (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 31/485 (2006.01); A61K 9/20 (2006.01); A61K 9/16 (2006.01); A61K 9/28 (2006.01);
U.S. Cl.
CPC ...
A61K 31/485 (2013.01); A61K 9/00 (2013.01); A61K 9/1635 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/0087 (2013.01); A61K 9/1617 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2081 (2013.01); A61K 9/282 (2013.01); A61K 9/2846 (2013.01); A61K 9/2866 (2013.01);
Abstract
A solid oral controlled-release oral dosage form of hydrocodone is disclosed. The dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and a sufficient amount of a controlled release material to render the dosage form suitable for twice-a-day administration to a human patient, the dosage form providing a C/Cratio of 0.55 to 0.85, said dosage form providing a therapeutic effect for at least about 12 hours.